本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akero Therapeutics

45.61
+2.575.97%
盘前46.921.31+2.87%08:15 EDT
成交量:148.07万
成交额:6,630.73万
市值:36.31亿
市盈率:-12.15
高:45.81
开:42.90
低:42.71
收:43.04
数据加载中...
2025/04/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/28

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/30

重要事件披露

Form 8-K - Current report
2025/01/28

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/27

重要事件披露

Form 8-K - Current report
2025/01/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/12/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report